3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Phase 2
1
Status
Withdrawn
2
Completed
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Conditions
Breast Neoplasms
10
Neoplasms
9
Polycystic Ovary Syndrome
8
Infertility
5
Liver Neoplasms
4
Pain, Postoperative
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Hepatocellular
3
Urinary Bladder Neoplasms
2
Recurrence
2
Pulmonary Embolism
2
Prostatic Neoplasms
2
Pleural Effusion
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neuroma, Acoustic
2
Melanoma
2
Lymphoma, Follicular
2
Leiomyoma
2
Inflammation
2
Febrile Neutropenia
2
Colorectal Neoplasms
2
Bites and Stings
2
Anovulation
2
Vomiting
1
Venous Thrombosis
1
Venous Thromboembolism
1
Interventions
Lidocaine
1
Levobupivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Withdrawn
×
Bites and Stings
×
Clear all
NCT02121951
2018-04-10
QLB
National Cancer Institute, Egypt
Phase 4
Withdrawn
NCT01903850
2016-02-02
TAO
CSA Medical, Inc.
Phase 4
Withdrawn